hero-line-left hero-line-top

The #1 platform for precision medicine

Syapse Oncology enables healthcare providers to deliver consistent, cost-effective, patient-centered cancer care.


The complexity of precision medicine is a job for software

Syapse Oncology is a point-of-care solution that:

icon circle checkmark Empowers care teams and service line leaders with insights that inform clinical and business decisions.
icon circle checkmark Integrates clinical, molecular, treatment, and outcomes data to create a structured, foundational database for the precision medicine program.
icon circle checkmark Enables the sharing of real-world evidence and clinical best practices with a trusted network of leading health systems.
  • Power patient-specific decision support

    Receive treatment guidance at the point of care.

  • Learn from real-world evidence

    View which treatments produced the best outcomes in similar patients.

  • Match patients to clinical trials

    Streamline the process of finding patients for clinical trials

All your patient data, now in one place

Easily access unified, longitudinal clinical and molecular data, embedded in your electronic medical record system. 

Automated clinical trial pre-screening

Identify patients who may be eligible for clinical trials with automated pre-screening built into the software.

Real-world evidence at your fingertips

View which treatments produced the best outcomes for patients like yours with the Syapse Data Sharing Network of clinical, molecular, treatment, and outcomes data. 

Molecular tumor boards made easier

Auto-assemble relevant data for molecular tumor boards, access cases whenever and wherever, and track recommendations after MTB review is complete.

Inform treatment and testing choices

Access treatment options sourced from real-world evidence, clinical trial matches, MTB case review, lab interpretations, and NCCN compendia. 

“Syapse has been critical to helping us scale our precision medicine program and data sharing efforts. We’re beginning to see better outcomes for patients, lower costs for payers, and more patients choosing to stay in the community for advanced cancer care.”
Derrick S. Haslem, MD
Derrick S. Haslem, MD
Director of Medical Oncology, Intermountain Healthcare


  • Syapse Data Sharing Network brochure (PDF)
  • Syapse Oncology overview brochure (PDF)
  • Implementing an Oncology Precision Medicine Clinic in a Large Community Health System,” by Thompson, et al. in AJMC
  • Building a Personalized Medicine Program,” by Thomas D. Brown of the Swedish Cancer Institute
  • How and When to Implement Precision Oncology,” by Lincoln Nadauld and Derrick S. Haslem of Intermountain Health
  • Role of Community-Based Genomics Programs,” by Thomas D. Brown of the Swedish Cancer Institute

In the news

Amgen taps Syapse to infuse real-world data into its cancer clinical trial designs

5/2/19 - Precision medicine company Syapse has launched a collaboration with its one-time Big Pharma benefactor Amgen, with the goal of mining real-world evidence for insights into cancer drug development. Together, Amgen and Syapse will develop observational research analytics aimed at assessing outcomes in areas of unmet need—starting by identifying existing patients within Syapse’s health network that may be eligible for clinical trials, and then bringing those studies to nearby sites.



Syapse Expands Security Posture with HITRUST Certification

Patient data collected from electronic health records, molecular testing and patient reported outcomes is powering many of the most exciting…